Studies have shown that GSTs gene polymorphisms might aid to identify high-risk individuals of chronic diseases such as type 2 diabetes mellitus (T2DM), hypertension and so on [16–18]. This evidence concerns the gene HPGDS and type 2 diabetes mellitus.